EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages

Robert Lodge iD, Zaikun Xu, Mckenna Eklund, Christina Stürzel, Frank Kirchhoff, Michel J Tremblay, Tom C Hobman, Éric A Cohen iD

mBio · 31.10.2023 · 14 (5)

DOI: 10.1128/mbio.01950-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 31.10.2023. Verfasst von Robert Lodge und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Retrovirology, Institut de recherches cliniques de Montréal (IRCM) , Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, HIV Seropositivity, MicroRNAs. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gouvernement du Canada | Canadian Institutes of Health Research (IRSC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The type 1 interferon-regulated E3 ubiquitin ligase MARCH1 reduces surface expression of HIV-1 envelope glycoproteins (Env) and their packaging into nascent virions, a condition that restricts viral infectivity. However, how HIV-1 counters this restriction, notably during infection of macrophages, remains unclear. Here, we show that the HIV-1 accessory protein Vpu increases the levels of microRNAs-25 and -93 to target MARCH1 mRNA. By recruiting β-TRCP, a component of the SCF β-TRCP E3 ligase complex that targets phosphorylated β-catenin for degradation, Vpu increases β-catenin levels, which, in concert with TCF4/LEF, drives transcription of the MARCH1 -targeting microRNAs. This potentiates HIV-1 infectivity as a result of increased Env incorporation into nascent virions. Pharmacological targeting of the β-catenin pathway inhibits Vpu-mediated upregulation of microRNAs-25 and -93 and restores MARCH1 restriction on HIV-1 infectivity. Overall, our findings highlight a novel mechanism by which HIV-1 counteracts MARCH1 by downregulating its expression via Vpu-mediated induction of microRNAs-25 and -93. IMPORTANCE In order to efficiently produce infectious viral particles, HIV must counter several restrictions exerted by host cell antiviral proteins. MARCH1 is a member of the MARCH protein family that restricts HIV infection by limiting the incorporation of viral envelope glycoproteins into nascent virions. Here, we identified two regulatory RNAs, microRNAs-25 and -93, induced by the HIV-1 accessory protein Vpu, that downregulate MARCH1 mRNA. We also show that Vpu induces these cellular microRNAs in macrophages by hijacking the cellular β-catenin pathway. The notion that HIV-1 has evolved a mechanism to counteract MARCH1 restriction on viral infectivity underlines the importance of MARCH1 in the host antiviral response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV-1HIV SeropositivityMicroRNAsHumansViral Regulatory and Accessory ProteinsHuman Immunodeficiency Virus ProteinsAntiviral AgentsMacrophagesGPI-Linked Proteins

Stichwörter der Autor:innen

HIV-1 countermeasuresMARCH proteinsVpubeta-cateninhuman immunodeficiency virusmacrophagesmicroRNArestriction factortype-I interferon responseviral glycoproteins

Substanzen

Viral Regulatory and Accessory ProteinsHuman Immunodeficiency Virus ProteinsAntiviral AgentsMicroRNAsGPI-Linked ProteinsMIRN25 microRNA, human

Autor:innen und Institutionen

  • Laboratory of Human Retrovirology, Institut de recherches cliniques de Montréal (IRCM) , Montreal, Quebec, Canada.
  • Department of Cell Biology, University of Alberta , Edmonton, Alberta, Canada.
  • Institute of Molecular Virology, Ulm University Medical Center , Ulm, Germany.
  • Centre de recherche du centre hospitalier universitaire de Québec, Université Laval , Quebec City, Quebec, Canada.
  • Département de microbiologie-infectiologie et immunologie, Faculté de médecine, Université Laval , Quebec City, Quebec, Canada.
  • Department of Medical Microbiology and Immunology, University of Alberta , Edmonton, Alberta, Canada.

ORCID-Profile: Robert Lodge, Éric A Cohen

Förderung

  • Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)

Zitieren

APA

Lodge, R., Xu, Z., Eklund, M., Stürzel, C., Kirchhoff, F., Tremblay, M. J., Hobman, T. C., & Cohen, É. A. (2023). MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages. mBio, 14(5). https://doi.org/10.1128/mbio.01950-23

Vancouver

Lodge R, Xu Z, Eklund M, Stürzel C, Kirchhoff F, Tremblay MJ, et al. MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages. mBio. 2023;14(5). doi:10.1128/mbio.01950-23

BibTeX
@article{Lodge2023,
  author = {Lodge, Robert and Xu, Zaikun and Eklund, Mckenna and Stürzel, Christina and Kirchhoff, Frank and Tremblay, Michel J and Hobman, Tom C and Cohen, Éric A},
  title = {MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages},
  journal = {mBio},
  year = {2023},
  volume = {14},
  number = {5},
  doi = {10.1128/mbio.01950-23}
}
Kostenlos starten →